StockData
Cerenome, Inc. logo

Cerenome, Inc. (CNSY) stock

CNSYNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 8/3071% below fair value
$0.63−0.08 (-11.82%)

Close on Nov 17, 2026Market cap $4.78MP/E –Yield –

Cerenome r&d expenses

Research and development expenses are spending on new products and technology.

Cerenome's R&D Expenses for the twelve months ending Jun 30, 2026 was $12.51M, up 55.4% year over year. For fiscal 2025 it was $8.38M, down 20.8% from the year before. Over ten years it grew -7.9% a year on average. The highest annual figure on record is $19.00M in fiscal 2015.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$8.38M-20.8%
FY2024Dec 31, 2024$10.58M+9.2%
FY2023Dec 31, 2023$9.69M-0.1%
FY2022Dec 31, 2022$9.70M+82.2%
FY2021Dec 31, 2021$5.32M+97.1%
FY2020Dec 31, 2020$2.70M-49.7%
FY2019Dec 31, 2019$5.37M-2.9%
FY2018Dec 31, 2018$5.52M-52.7%
FY2017Dec 31, 2017$11.68M-27.9%
FY2016Dec 31, 2016$16.20M-14.8%
FY2015Dec 31, 2015$19.00M+25.8%
FY2014Dec 31, 2014$15.11M-11.5%
FY2013Dec 31, 2013$17.07M+25.2%
FY2012Dec 31, 2012$13.63M+25.0%
FY2011Dec 31, 2011$10.90M+12.6%
FY2010Dec 31, 2010$9.69M-20.8%
FY2009Dec 31, 2009$12.23M–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$4.27M+242.3%
Q1 FY2026Mar 31, 2026$2.87M+63.2%
Q4 FY2025Dec 31, 2025$2.94M+34.5%
Q3 FY2025Sep 30, 2025$2.44M-14.8%
Q2 FY2025Jun 30, 2025$1.25M-55.1%
Q1 FY2025Mar 31, 2025$1.76M-36.4%
Q4 FY2024Dec 31, 2024$2.19M-21.8%
Q3 FY2024Sep 30, 2024$2.86M+14.6%
Q2 FY2024Jun 30, 2024$2.77M+95.3%
Q1 FY2024Mar 31, 2024$2.76M-7.4%
Q4 FY2023Dec 31, 2023$2.79M+30.7%
Q3 FY2023Sep 30, 2023$2.49M-15.3%
Q2 FY2023Jun 30, 2023$1.42M-49.8%
Q1 FY2023Mar 31, 2023$2.98M+67.1%
Q4 FY2022Dec 31, 2022$2.14M+33.7%
Q3 FY2022Sep 30, 2022$2.95M+97.5%
Q2 FY2022Jun 30, 2022$2.83M+156.0%
Q1 FY2022Mar 31, 2022$1.79M+58.4%
Q4 FY2021Dec 31, 2021$1.60M+45.9%
Q3 FY2021Sep 30, 2021$1.49M+343.8%
Q2 FY2021Jun 30, 2021$1.11M+238.2%
Q1 FY2021Mar 31, 2021$1.13M+19.8%
Q4 FY2020Dec 31, 2020$1.10M-36.6%
Q3 FY2020Sep 30, 2020$336.00K-63.5%
Q2 FY2020Jun 30, 2020$327.00K-74.6%
Q1 FY2020Mar 31, 2020$941.00K-34.0%
Q4 FY2019Dec 31, 2019$1.73M+5.7%
Q3 FY2019Sep 30, 2019$921.00K-63.1%
Q2 FY2019Jun 30, 2019$1.29M-46.2%
Q1 FY2019Mar 31, 2019$1.43M-52.5%
Q4 FY2018Dec 31, 2018$1.64M-45.3%
Q1 FY2018Mar 31, 2018$2.50M-24.0%
Q4 FY2017Dec 31, 2017$2.39M-16.4%
Q3 FY2017Sep 30, 2017$3.00M-24.1%
Q2 FY2017Jun 30, 2017$2.99M-43.0%
Q1 FY2017Mar 31, 2017$3.29M–
Q4 FY2016Dec 31, 2016$2.86M–
Q3 FY2016Sep 30, 2016$3.96M–
Q2 FY2016Jun 30, 2016$5.25M–

More Cerenome figures

See a number that looks wrong?